In ₹ Crore except Per Share Latest Annual	BNAGROCHEM FY25	ASIANTNE FY25	CFEL FY24	CRAVATEX FY22	Peer Average
Valuation — at last close
P/E	—	99.78×	33.01×	◆ 19.05×	50.61×
P/B	—	◆ 0.33×	0.61×	1.98×	0.97×
EV/EBITDA	—	87.99×	◆ -1039.92×	-29.48×	-327.14×
Market Cap	—	₹17.8 Cr	₹84.5 Cr	₹83.6 Cr	₹62 Cr
Profitability
EBITDA Margin	-12.51%	◆ 0.69%	-1.69%	-120.33%	-40.44% +69%
Net Income Margin	6.60%	0.35%	50.62%	◆ 179.59%	76.85% -91%
Return on Common Equity	10.34%	0.36%	1.85%	◆ 10.41%	4.21% +146%
Return on Capital Employed	-17.55%	◆ 0.62%	-0.16%	-5.82%	-1.79% -882%
Return on Assets	◆ 8.89%	0.26%	1.77%	8.15%	3.39% +162%
Credit & Quality
Total Debt/Equity	0.14×	0.24×	◆ 0.03×	0.10×	0.12× +14%
Interest Coverage	-4.31×	◆ 0.19×	-3.05×	-4.08×	-2.31× -86%
Scale — latest FY
Revenue / Total Income	₹299 Cr	₹50.9 Cr	₹5.1 Cr	₹2.4 Cr	₹19.5 Cr +1438%
Net Income	₹19.8 Cr	₹0.2 Cr	₹2.6 Cr	₹4.4 Cr	₹2.4 Cr +731%
Total Assets	₹372 Cr	₹71.7 Cr	₹144 Cr	₹53.9 Cr	₹90 Cr +313%
EPS	—	₹0.09	₹1.02	₹16.98	₹6.03
Book Value per Share	—	₹27.18	₹55.22	₹163.17	₹81.86

◆ best value in the comp set per metric · Δ = subject vs average of the other companies.

« ‹ › »Latest: FY25 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.